ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a ...
Our lab data proves you can find top-performing cordless vacuums with long-lasting batteries and strong suction without ...
CASGEVY is the first, and only, gene editing therapy approved for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD) in Europe -- Italy has the largest ...
Good morning, everybody. Welcome to the Bank of America Healthcare Conference, our London version. I'm pleased to be kicking off the conference with our first presenting company, Vertex. Presenting ...
Zacks Investment Research on MSN
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...
The thalassemia market is primarily driven by regular blood transfusions and iron chelation therapies, which help manage anemia and prevent iron overload. Curative treatments, such as stem cell ...
Regeneron Pharmaceuticals just announced promising results from their Phase 3 study on allergen-blocking antibodies, ...
PepsiCo has been quietly navigating the market's turbulent waters, with its share price declining nearly 20% over the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback